- General Dermatology
- Eczema
- Alopecia
- Aesthetics
- Vitiligo
- COVID-19
- Actinic Keratosis
- Precision Medicine and Biologics
- Rare Disease
- Wound Care
- Rosacea
- Psoriasis
- Psoriatic Arthritis
- Atopic Dermatitis
- Melasma
- NP and PA
- Skin Cancer
- Hidradenitis Suppurativa
- Drug Watch
- Pigmentary Disorders
- Acne
- Pediatric Dermatology
- Practice Management
SDPA Annual Summer Dermatology Conference Recap: Day 3
Catch up on coverage from the third day of the 2023 SDPA Annual Summer Dermatology Conference.
eskystudio/AdobeStock
Conservative Imputation Method Efficacious in Moderate-to-Severe Hidradenitis Suppurativa
With bimekizumab, the conservative imputation method led to higher response rates, achieved endpoints, and blocked IL-17A and IL-17F.
Abrocitinib Did Not Impact Immune Responses to Vaccination in Adolescents With Atopic Dermatitis
A poster presented at the SDPA Annual Summer Dermatology Conference revealed the abrocitinib did not have a significant impact on adolescent immune responses to Tdap vaccination.
Recognizing and Treating Hidradenitis Suppurativa With Joslyn Kirby, MD
Joslyn Kirby, MD, discusses the importance of awareness and recognition in hidradenitis suppurativa from a clinician and patient perspective.
Addressing Cutaneous Blisters and Chronic Bullous Disorders With Megan Noe, MD, MPH, MSCE
Megan Noe, MD, MPH, MSCE, reviews best practices for treating patients with cutaneous blisters and managing chronic bullous disorders.
Choosing a Biologic in Psoriasis With Ahmad Amin, MD, FAAD
Ahmad Amin, MD, FAAD, reviews biologic selection in patients with psoriatic disease.
For a full list of conference coverage from the SDPA Annual Summer Dermatology Conference, visit our conference page.
